Lorazepam
- Product NDC
- 53002-6290
- 11-digit product format
- 530026290
- Labeler code
- 53002
- Product ID
- 53002-6290_41bd0cb0-71a1-426a-bc2f-1841a766f739
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA078203
- Marketing category
- ANDA
- Marketing start
- 2007-10-01
- Marketing end
- 0000-00-00
- Substance
- LORAZEPAM
- Active strength
- 2 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-6290-1 | Lorazepam | 10 in 1 BOTTLE | TABLET | 10 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-6290 | LORAZEPAM TABLET [RPK PHARMACEUTICALS, INC.] | 6 | Legacy NDC, 1 package rows | 20230609_076179cd-0974-4153-9ac6-375e51234635.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-6290-1 | 53002629001 | 10 TABLET in 1 BOTTLE (53002-6290-1) | 10 tablet | 2017-10-01 | 0000-00-00 | No | No | Current |